MIST logo

MIST
Milestone Pharmaceuticals Inc

7,185
Mkt Cap
$118.84M
Volume
4.5M
52W High
$3.06
52W Low
$0.6254
PE Ratio
-1.27
MIST Fundamentals
Price
$1.19
Prev Close
$1.01
Open
$1.06
50D MA
$1.70
Beta
1.41
Avg. Volume
1.77M
EPS (Annual)
-$0.7517
P/B
2.57
Rev/Employee
$40,684.21
$121.86
Loading...
Loading...
News
all
press releases
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Consensus Recommendation of "Hold" from Brokerages
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) has been assigned an average recommendation of "Hold" from the six ratings firms that are currently covering the company, Marketbeat.com...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Milestone Pharmaceuticals (NASDAQ:MIST) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded Milestone Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·4d ago
News Placeholder
Milestone Pharmaceuticals (MIST) Projected to Post Earnings on Tuesday
Milestone Pharmaceuticals (NASDAQ:MIST) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 31. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Equities Analysts Issue Forecasts for MIST FY2028 Earnings
Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) - Equities researchers at HC Wainwright lowered their FY2028 earnings per share estimates for shares of Milestone Pharmaceuticals in a research report issued on Friday, March 20th. HC Wainwright analyst B. Folkes now forecasts that the compa...
MarketBeat·9d ago
News Placeholder
Milestone Pharmaceuticals (NASDAQ:MIST) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Milestone Pharmaceuticals (NASDAQ:MIST - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. The firm had revenue of $1.44 million during the quarter, compared to the...
MarketBeat·10d ago
News Placeholder
Milestone Pharmaceuticals Q4 Earnings Call Highlights
Milestone Pharmaceuticals (NASDAQ:MIST) executives highlighted the company's transition to commercialization during a year-end 2025 update call, following the U.S. Food and Drug Administration's...
MarketBeat·11d ago
News Placeholder
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Earnings report for Milestone Pharmaceuticals Inc. (MIST) expected on March 19. Analysts predict 16 cents per share on $1.20M revenue.read more...
Benzinga·12d ago
News Placeholder
Boxer Capital Management LLC Invests $1.33 Million in Milestone Pharmaceuticals Inc. $MIST
Boxer Capital Management LLC purchased a new stake in shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) during the third quarter, according to its most recent Form 13F filing with...
MarketBeat·17d ago
News Placeholder
Milestone Pharmaceuticals Inc. $MIST Shares Purchased by Propel Bio Management LLC
Propel Bio Management LLC boosted its holdings in shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) by 186.1% during the 3rd quarter, according to its most recent filing with the...
MarketBeat·26d ago
News Placeholder
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Receives Average Rating of "Hold" from Brokerages
Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Get Free Report) have received a consensus recommendation of "Hold" from the six analysts that are presently covering the company, MarketBeat...
MarketBeat·27d ago
<
1
2
...
>

Latest MIST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.